- Home
- DALN vs IRIX Comparison
DALN vs IRIX Comparison
Compare DALN & IRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DALN
- IRIX
- Stock Information
- Founded
- DALN 1954
- IRIX 1989
- Country
- DALN United States
- IRIX United States
- Employees
- DALN N/A
- IRIX N/A
- Industry
- DALN Newspapers/Magazines
- IRIX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- DALN Consumer Discretionary
- IRIX Health Care
- Exchange
- DALN Nasdaq
- IRIX Nasdaq
- Market Cap
- DALN 24.6M
- IRIX 28.6M
- IPO Year
- DALN 2008
- IRIX 1996
- Fundamental
- Price
- DALN $6.70
- IRIX $1.69
- Analyst Decision
- DALN
- IRIX Hold
- Analyst Count
- DALN 0
- IRIX 1
- Target Price
- DALN N/A
- IRIX $2.00
- AVG Volume (30 Days)
- DALN 52.2K
- IRIX 46.3K
- Earning Date
- DALN 03-05-2025
- IRIX 11-12-2024
- Dividend Yield
- DALN 2.39%
- IRIX N/A
- EPS Growth
- DALN N/A
- IRIX N/A
- EPS
- DALN N/A
- IRIX N/A
- Revenue
- DALN $128,286,000.00
- IRIX $48,431,000.00
- Revenue This Year
- DALN N/A
- IRIX N/A
- Revenue Next Year
- DALN N/A
- IRIX $5.44
- P/E Ratio
- DALN N/A
- IRIX N/A
- Revenue Growth
- DALN N/A
- IRIX N/A
- 52 Week Low
- DALN $2.98
- IRIX $1.27
- 52 Week High
- DALN $7.86
- IRIX $3.65
- Technical
- Relative Strength Index (RSI)
- DALN 49.01
- IRIX 49.97
- Support Level
- DALN $6.75
- IRIX $1.63
- Resistance Level
- DALN $7.19
- IRIX $1.67
- Average True Range (ATR)
- DALN 0.32
- IRIX 0.10
- MACD
- DALN -0.13
- IRIX -0.00
- Stochastic Oscillator
- DALN 0.00
- IRIX 37.93
About DALN DallasNews Corporation Series A
DallasNews Corp is a local news and information publishing company in Texas with commercial printing, distribution, and direct mail capabilities, as well as a presence in emerging media and digital marketing.
About IRIX IRIDEX Corporation
IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.